News
Critics fear that U.S. Department of Health and Human Services chief RFK, Jr., known for his antivaccine views, has picked a ...
The NDIN review process follows the Federal Food, Drug, and Cosmetic Act (the FD&C Act) requirement that manufacturers and ...
MENLO PARK, Calif., June 16, 2025 (GLOBE NEWSWIRE) -- Inquis Medical, the leading innovator in the treatment of venous ...
Popular vitamins taken by one in four Americans and sold at major retailers like ALDI have been recalled due to ...
Another person treated with Elevidys suffered acute liver failure, leading Sarepta to discontinue treatment in certain patients while it evaluates new safety precautions.
Cambridge-based Sarepta Therapeutics said it was halting shipments of its Duchenne muscular dystrophy gene therapy for ...
Explore more
Yesterday, the New York Times reported that the FDA, in collaboration with USDA and other government agencies, plans to ...
In today's Pharmalittle roundup, we're reading about a Sarepta setback with its Duchenne drug, the FDA workload causing a ...
The move follows an announcement by Secretary Robert F. Kennedy Jr. that the FDA will be conducting a review of mifepristone.
Sarepta's stock drops on ELEVIDYS safety concerns, yet potential remains for ambulatory patients. Click here to read an ...
Turkana is issuing a recall of its Florida dried apricots in 20 states, including Texas, due to undeclared allergens.
The products contain a drug called tianeptine, which is addictive and has not been FDA approved. 'Nation of immigrants and a nation of laws': Obama speaks out about immigration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results